The global process spectroscopy market size is projected to reach USD 41.99 billion by 2030, registering a CAGR of 11.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for advanced research and development has led to the adoption of various spectroscopy techniques significantly across the pharmaceutical industry during the forecast period. The growing emphasis on maintaining high-quality standards is driving technology’s growth.
Additionally, there is a rising focus on reducing operational costs, expected to drive the demand for spectroscopic devices in the coming years. The market players in the pharmaceutical industry engaging in extensive research and development have yielded the discovery of numerous drugs, resulting in the development of effective medications to combat various diseases and disabilities on a global scale. The continuous adoption of spectroscopic procedures and associated equipment installations will contribute to substantial market growth throughout the forecast period. Moreover, the market is expected to experience significant expansion in the coming years due to increasing awareness of high-quality spectroscopic devices among end-use industries.
Process spectroscopy refers to applying spectroscopic techniques for real-time monitoring and analysis of chemical, physical, or biological processes. It involves the use of various spectroscopic methods such as infrared (IR) spectroscopy, Raman spectroscopy, ultraviolet-visible (UV-Vis) spectroscopy, and nuclear magnetic resonance (NMR) spectroscopy, among others. The techniques utilized in process spectroscopy rely on the interaction of electromagnetic radiation with matter. They measure the absorption, emission, or scattering of light by molecules, allowing for the identification and quantification of various compounds and their properties.
The COVID-19 pandemic caused disruptions in global supply chains, subsequently impacting the market. This led to delays in manufacturing, delivering, and installing spectroscopy equipment and components. In the wake of the pandemic, the most challenging aspects have been the lack of testing to trace and identify infections. On the other hand, the pandemic increased the demand for process spectroscopy in pharmaceutical applications. The urgent need for vaccines, treatments, and diagnostics related to COVID-19 created opportunities for the market. Spectroscopic techniques are essential in drug development, quality control, and process optimization, contributing to the market's growth in the pharmaceutical industry.
The researchers developed a novel test technology for detecting the coronavirus, utilizing physics. By leveraging principles of physics, this innovative test technology offers a promising alternative to traditional biochemical-based tests. For instance, in 2020, a research team at Northern Arizona University developed a surface-enhanced single-molecule Raman spectroscopy (SM-SERS), which would identify the S proteins of the SARs-Cov-2 virus, involved in the virus at the cellular level.
The market for process spectroscopy is highly consolidated. Some prominent players in the market include Agilent Technologies, Inc.; Bruker; Danaher Corporation; Shimadzu Corporation; and Thermo Fisher Scientific, Inc. The industry participants are adopting process spectroscopic instruments to enhance product quality and adhere to international standards such as ISO and Six Sigma. The companies operating in this market are making huge investments in research and development initiatives.
Market players are involved in several strategic initiatives to achieve a competitive advantage, such as acquisitions, mergers, partnerships, and new product launches. For instance, in August 2022, Danaher Corporation announced that the company had acquired Aldevron. Aldevron would be branded within the Life Science segment of Danaher Corporation and operate as a standalone company.
Request a free sample copy or view report summary: Process Spectroscopy Market Report
The hardware segment dominated with a market share of 77.0% in 2023 and is expected to witness a CAGR of 10.34% during the forecast period
The pharmaceutical application segment dominated in 2023, gaining a revenue share of 31.8%. It is expected to grow at a CAGR of 11.08% throughout the forecast period
The molecular technology segment held the largest revenue share of 45.1% in 2023. It is expected to grow at a CAGR of 10.40% throughout the forecast period
Molecular spectroscopy led the market and accounted for a 45.1% share of the global revenue in 2023
The primary source markets are the U.S., Japan, China, India, the UK, and Canada. The U.S. is expected to be the primary source market for process spectroscopy industry players
Grand View Research has segmented the global process spectroscopy market report based on component, technology, application, and region.
Process Spectroscopy Component Outlook (Revenue, USD Billion; 2017 - 2030)
Hardware
Software
Process Spectroscopy Technology Outlook (Revenue, USD Billion; Shipment, Units; ASP, USD; 2017 - 2030)
Molecular Spectroscopy
NIR
FT-IR
Raman
NMR
Others
Mass Spectroscopy
Atomic Spectroscopy
Process Spectroscopy Application Outlook (Revenue, USD Billion; 2017 - 2030)
Polymer
Oil & Gas
Pharmaceutical
Food & Agriculture
Chemical
Water & Wastewater
Pulp & Paper
Metal & Mining
Others
Process Spectroscopy Regional Outlook (Revenue, USD Billion; 2017 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Asia Pacific
China
Japan
India
South Korea
Australia
South America
Brazil
Middle East and Africa (MEA)
Kingdom of Saudi Arabia (KSA)
UAE
South Africa
List of Key Players of Process Spectroscopy Market
ABB
Agilent Technologies, Inc.
Bruker
BUCHI
Danaher
FOSS
HORIBA
Endress+Hauser Group Services AG
Sartorius AG
Shimadzu Corporation
Thermo Fisher Scientific Inc.
Yokogawa Electric Corporation